Motley Fool Premium
  1. Stocks
    2. /
  2. Novacyt (LSE: NCYT)
    3. /

LSE:NCYT (Novacyt)

About NCYT

Novacyt SAS engages in the development and sale of cancer and infectious disease diagnostic products. It operates through the Corporate and Diagnostics; and Molecular Products segments. The Corporate and Diagnostics segment includes diagnostic activities in laboratories, and the manufacturing and distribution of reagents and kits for bacterial and blood tests. The Molecular Products segment comprises of design, manufacture, and distribution of test kits for certain diseases in humans, animals and food products. The company was founded by Eric Peltier, Gerald Ulrich, and Jean-Pierre Crinelli on July 3, 2006 and is headquartered in Velizy-Villacoublay, France.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Novacyt (LSE: NCYT) Latest News

Investing Articles

The Novacyt share price is up over 10,000% but I still think it’s a buy

| James J. McCombie

The price of Novacyt stock has soared, but I think its success in coronavirus tests has laid the groundwork for…

Read more »

Investing Articles

Interested in the Novacyt share price? Read this first!

| Tom Rodgers

The Novacyt share price has made early investors rich. Is the Covid-19 testing firm still a buy in 2020? Tom…

Read more »

Investing Articles

Novacyt shares have doubled in a month. Should you keep buying?

| Roland Head

Strong demand for Covid-19 testing products has put a rocket under the Novacyt share price. But will pandemic success translate…

Read more »

Investing Articles

Is the Novacyt share price too high? Here’s what you need to know

| Toby Aston

The Novacyt share price is soaring after a strong H1 earnings announcement. But does that mean you should be buying?

Read more »

Investing Articles

My best shares to buy now for UK investors during the crisis

| Anna Sokolidou

Many people want to find the best shares to buy now. But how should one do so? Anna Sokolidou thinks…

Read more »

Investing Articles

Novacyt shares have soared! Are they a buy right now?

| Anna Sokolidou

Novacyt shares have rallied wildly! Are they still a buy right now? Anna Sokolidou tries to find out.

Read more »

Investing Articles

The Novacyt share price has 20-bagged in 2020. Is there still time to buy?

| Alan Oscroft

The Novacyt share price is flying as sales of Covid-19 tests soar. Alan Oscroft asks if the share price represents…

Read more »

Investing Articles

The Novacyt share price has risen 2,500% this year! Is it worth adding to your ISA?

| Toby Aston

The Novacyt share price is up! The biotech company is making Covid-19 testing kits for the UK government. But is…

Read more »

Investing Articles

Novacyt share price surged 2,650% year-to-date! Can this wild ride continue?

| Kirsteen Mackay

The Novacyt share price is experiencing volatility as it commits to increasing coronavirus test orders. Can it meet market expectations?

Read more »

Investing Articles

Novacyt exploded higher, and I’m finding other strong-performing shares too

| Kevin Godbold

One thing I’m sure about more than anything right now. Stock-picking is king. And I’m finding some great shares. Here’s…

Read more »

Investing Articles

Can coronavirus test-maker Novacyt still make you rich?

| Paul Summers

Coronavirus test-producer Novacyt (LON:NCYT) has likely made some savvy small-cap investors very wealthy. Could it still make money for new…

Read more »

Investing Articles

Coronavirus test maker Novacyt is up 2,750%! Here’s what I’d do now

| Tom Rodgers

Coronavirus testing company Novacyt has made early investors rich. With antibody testing on the way, Tom Rodgers looks at the…

Read more »